Risk of structural persistent disease in pediatric patients with low or intermediate risk differentiated thyroid cancer.
Michele KlainEmilia ZampellaMariarosaria ManganelliValeria GaudieriCarmela NappiAdriana D'AntonioLeandra PiscopoFabio VolpeLeonardo PaceMartin SchlumbergerAlberto CuocoloPublished in: Endocrine (2020)
In pediatric patients with DTC, postoperative high stimulated Tg values (>10 ng/ml) should be taken into account for deciding the extent of both initial treatment and follow-up.